Our Company

Tatyana Kosheleva, CPA, MBA

VP Treasurer & CFO

Tatyana Kosheleva is Head, Finance and Corporate Treasurer for Amring Pharmaceuticals Inc. In this role, Ms. Kosheleva is responsible for supporting the company’s financial growth. She oversees forecasting and planning, accounting, liquidity management, internal controls, compliance, purchasing, and bank and audit relationship management. Ms. Kosheleva is a member of Amring’s Executive Board, and reports directly to the President of Amring.

Ms. Kosheleva has extensive international financial and operational expertise, with a career that spans more than two decades and four countries. Before joining Amring, she was Finance Director at Russian subsidiary of Ferring Pharmaceuticals. Prior to that, Ms. Kosheleva served as Chief Financial Officer at DST Global Solutions, a London-based subsidiary of DST Systems, with offices in nine countries.

Ms. Kosheleva is a licensed CPA and holds an MBA from Thunderbird School of Global Management, a part of the Arizona State University.

Marina Volin, Esq.

VP, General Counsel & Corporate Secretary

Marina joined Amring Pharmaceuticals in May 2020 as Vice President, General Counsel & Corporate Secretary. She oversees all legal matters for the company including contractual agreements, corporate governance, intellectual property, compliance matters and due diligence for business development opportunities.
With more than 20 years of experience representing pharmaceutical companies, Marina came to Amring from Kintai Therapeutics of Cambridge, MA where she served as Vice President, Head of Legal and Intellectual Property. Prior to that, she served as Intellectual Property and Corporate Attorney for Windtree Therapeutics, Inc. (formerly Discovery Labs) of Warrington, PA. Marina began her legal career with the law firm Caesar Rivise, PC of Philadelphia, PA. Prior to studying law, Marina served as Scientific Assistant at the Fox Chase Cancer Center, Philadelphia, PA.

Marina earned her Juris Doctorate degree from the Temple University School of Law in Philadelphia and Master of Science and Bachelor of Science degrees in Chemical Engineering from the Gubkin Russian University of Oil and Gas in Moscow. She is a member of the New Jersey and Pennsylvania Bar Associations.

Thomas Sammler

VP, Commercial Operation

As Vice President, Commercial Operation, Mr. Sammler is responsible for the strategy and tactical execution of the Amring commercial product portfolio. He leads the identification and pursuit of profitable sales growth at the national, regional, and local level, across Retail, Specialty and Institutional Pharmacy. He also helps carry out growth initiatives, such as business development activities, to ensure strong, sustained P&L performance for the company.

Before joining Amring in September 2015, Mr. Sammler was Director, Sales Operations for Impax Laboratories. In that position, he managed sales operations during the company’s integration with the Tower Holding companies. Previously, Mr. Sammler held various marketing and financial positions at CorePharma, Sandoz, Endo Pharmaceuticals and DuPont/DuPont Merck. He has experience driving revenues for both generic and branded pharmaceutical products and leading a diverse range of commercial operations, from sales teams and product marketing to supply chain logistics and strategic planning.

Mr. Sammler graduated with a B.S. in Accounting from Widener University and earned his MBA in Pharmaceutical Marketing from Saint Joseph’s University.

Steven Cowan

VP, Technical Operations and Development

Nancy Fulginiti

VP, Quality

Nancy joined Amring Pharmaceuticals in August 2022 as Vice President, Quality. She oversees quality assurance and regulatory compliance. She has more than 25 years of experience with quality in the pharmaceutical industry. Nancy came to Amring from CRISPR Therapeutics where she served as Vice President, Quality. Prior to that, she served as Audit Head for Novartis and Executive Director Quality for Sandoz.

Nancy holds a B.S. in Clinical Laboratory Science from Thomas Jefferson University and an M.S. in Clinical Chemistry from West Chester University.